PHASE 1B/2A Clinical trial started
April 13, 2021
The Nerofe Phase 1B/2A trial with high risk MDS and AML patients is taking place at the University of Miami Sylvester Comprehensive Cancer Center.
The prestigious medical center Georgetown University at Washington DC has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers.
ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases